Devises
Encours
Société de Gestion
Rechercher par nom de fonds
Importez des fonds de vos listes
Contient en portefeuille
Date d'émission
Performance Cumulée
Performance Annualisée
Investissement Initital minimum
Frais de Souscription
Frais de Rachat
Frais de gestion
Actions Secteur Biotechnologie
Capitalisation ou distribution
Affichage:
model.Par défautPar défaut | |
---|---|
Performances | |
Frais | |
Gestion |
Voulez-vous supprimer cette sauvegarde ?
Nom | Encours | Varia 1 janv. | Varia 3 ans | Notation | |
---|---|---|---|---|---|
Candriam Eqs L Biotech C USD Cap |
1 483 M
USD
| +5,77% | +6,75% | ||
Candriam Eqs L Biotech C USD Dis |
1 483 M
USD
| +5,75% | +6,65% | ||
Candriam Eqs L Biotech I USD Cap |
1 554 M
USD
| +6,07% | +6,91% | ||
Candriam Eqs L Biotech N USD Cap |
1 483 M
USD
| +5,58% | +5,43% | ||
Candriam Eqs L Biotech V USD Cap |
1 539 M
USD
| +6,13% | +7,31% | ||
Polar Capital Fd.Biotechnology R EUR |
1 597 M
EUR
| +8,46% | +22,78% | ||
Polar Capital Biotech I Inc
|
1 689 M
EUR
| +8,72% | +24,09% | ||
Polar Capital Biotech R Inc
|
394 M
GBP
| - | - | ||
Polar Capital Biotech R Inc |
1 657 M
USD
| +5,17% | +10,03% | ||
Polar Capital Biotech I Inc
|
394 M
GBP
| +6,26% | +22,34% | ||
Polar Capital Biotech I Inc |
1 657 M
USD
| +5,43% | +11,21% | ||
Candriam Eqs L Biotech R USD Cap |
1 483 M
USD
| +6,23% | +9,44% | ||
Polar Capital Biotech S Inc |
1 657 M
USD
| +5,56% | +12,52% | ||
Polar Capital Biotech S Inc
|
394 M
GBP
| - | - | ||
Polar Capital Biotech S Inc
|
445 M
EUR
| - | - | ||
Candriam Eqs L Biotech I EUR Cap |
1 366 M
EUR
| +9,38% | +19,34% | ||
Candriam Eqs L Biotech C EUR Cap |
1 366 M
EUR
| +9,04% | +18,93% | ||
Janus Henderson Hrzn Biotec A2 USD |
257 M
USD
| +10,26% | +24,09% | ||
Janus Henderson Hrzn Biotec H2 USD |
257 M
USD
| +10,47% | +24,60% | ||
Janus Henderson Hrzn Biotec IU2 USD |
257 M
USD
| +10,52% | +26,72% | ||
Candriam Eqs L Biotech V2 USD Cap |
1 483 M
USD
| +6,36% | +10,26% | ||
Franklin Biotechnology Discv I(acc)USD |
1 630 M
USD
| +9,47% | -1,24% | ||
Pictet-Biotech Z USD |
1 486 M
USD
| +5,42% | -1,79% | ||
Franklin Biotechnology Discv A(acc)SGD |
2 217 M
SGD
| +12,00% | -2,83% | ||
Franklin Biotechnology Discv Z(acc)GBP |
1 298 M
GBP
| +10,19% | +7,22% | ||
Franklin Biotechnology Discv W(acc)USD |
1 626 M
USD
| +9,40% | -1,38% | ||
Franklin Biotechnology Discv Z(acc)USD |
1 626 M
USD
| +9,26% | -2,26% | ||
HBM Global Biotechnology A Cap USD |
24 M
USD
| +4,24% | -6,28% | ||
HBM Global Biotechnology P Cap USD |
24 M
USD
| +4,31% | -5,27% | ||
Franklin Biotechnology Discv A(acc)USD |
1 630 M
USD
| +9,02% | -3,72% | ||
UBS (Lux) EF Biotech (USD) P-acc |
479 M
USD
| +2,38% | -10,54% | ||
Pictet-Biotech P USD |
1 507 M
USD
| +4,42% | -7,21% | ||
Franklin Biotechnology Discv N(acc)USD |
1 630 M
USD
| +8,60% | -5,87% | ||
Pictet-Biotech I USD |
1 507 M
USD
| +4,88% | -4,69% | ||
Pictet-Biotech R USD |
1 507 M
USD
| +4,05% | -9,15% | ||
Pictet-Biotech I EUR |
1 204 M
EUR
| +8,52% | +6,24% | ||
Pictet-Biotech P EUR |
1 204 M
EUR
| +8,03% | +3,42% | ||
Pictet-Biotech R EUR |
1 204 M
EUR
| +7,66% | +1,26% | ||
Franklin Biotechnology Discv C(acc)USD |
1 630 M
USD
| +8,70% | -5,39% | ||
Pictet-Biotech P dy USD |
1 507 M
USD
| +4,42% | -7,22% | ||